论文部分内容阅读
目的:探讨脑苷肌肽治疗脑梗死的临床效果。方法:本次研究的110例患者均为重庆市巴南区第二人民医院在2013年2月-2014年11月期间收治,将其按照治疗方式的不同分为观察组55例和对照组55例,观察组实施脑苷肌肽注射液治疗,对照组患者采用血塞通治疗,对比两组患者的治疗效果及并发症发生率。结果:观察组总有效率为98.18%,并发症发生率为3.64%;对照组总有效率为72.73%,并发症发生率为12.73%,差异具有统计学意义(P<0.05)。结论:脑苷肌肽治疗脑梗死效果良好,并发症发生率较低。
Objective: To investigate the clinical effect of cerebroside on cerebral infarction. Methods: All the 110 patients in this study were admitted to the Second People’s Hospital of Banan District in Chongqing from February 2013 to November 2014. The patients were divided into observation group (55 cases) and control group (55 cases) according to the different treatment methods For example, the observation group was treated with CGS injection, the control group was treated with Xuesaitong, and the treatment effect and complication rate were compared between the two groups. Results: The total effective rate was 98.18% in the observation group and the incidence of complications was 3.64%. The total effective rate in the control group was 72.73% and the complication rate was 12.73%. The difference was statistically significant (P <0.05). Conclusion: Cerebroside glycoside treatment of cerebral infarction with good results, the incidence of complications is low.